APSR2026-767

 
Regular
Submitted
Poster Presentation
 
AP05-006
P109
 
Format: PPTX Only
 
Format: PDF Only
12. Bronchoscopy and Interventional Techniques
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

DUSHANTHA MADEGEDARA * WAYAMBE UNIVERSITY FACULTY OF MEDINE KURUNAGALA Sri Lanka
DILKY RATHNAYAKE - WAYAMBE UNIVERSITY FACULTY OF MEDINE KURUNAGALA Sri Lanka
Sinduja Sriskandarajah - WAYAMBE UNIVERSITY FACULTY OF MEDINE KURUNAGALA Sri Lanka
Praveen Jayarathna - WAYAMBE UNIVERSITY FACULTY OF MEDINE KURUNAGALA Sri Lanka
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
DUSHANTHA
MADEGEDARA
dhanukshi@classictravel.lk
+94765251144
61-70
Sri Lanka
Original Research
Audit of fibreoptic bronchoscopy indications, diagnostic yield, and safety in a Sri Lankan tertiary care centre
Maximum 25 words
Abstract Content
<p>Fibreoptic bronchoscopy (FOB) is an essential diagnostic tool in respiratory medicine, with limited data on its utilisation, diagnostic yield, and safety in Sri Lankan tertiary care settings. This study evaluated the indications, outcomes, and safety of FOB at a tertiary care centre in Sri Lanka</p>
<p>A retrospective descriptive study was conducted on 621 patients undergoing fibreoptic bronchoscopy at the Respiratory and Research Unit 2, National Hospital Kandy (2020–2024). Procedures were performed using Olympus Evis Exera III CV-190 video bronchoscopes. Data on demographics, clinical indications, radiological findings, bronchoscopic observations, sampling modalities, and complications were extracted and analysed using SPSS with descriptive statistics and chi-square testing.</p>
<p>Among 621 patients (437 males, 70.4%), most were aged 60–79 years (52.3%). Leading indications were suspected malignancy (207, 33.3%), persistent cough (197, 31.7%), and suspected tuberculosis (75, 11.9%). </p><p>Chest radiography was performed in 99.7% (n=619), with abnormalities in 91.4% (n=566), while CT chest was performed in 13.4% (n=83), with abnormalities in 84.3% (n=70). Endobronchial abnormalities were detected in 52.8% (n=328) of the right lung and 41.2% (n=256) of the left, including mucosal inflammation, secretions, obstruction, and extrinsic compression. Malignancy was confirmed in 14.2% (n=88), while bronchoalveolar lavage identified tuberculosis in 9.2% (n=57). </p><p>Mean symptom duration was longest for weight loss (8.63 weeks) and persistent cough (8.41 weeks), followed by shortness of breath (7.74 weeks) and loss of appetite (7.40 weeks), indicating delayed presentation. The procedure demonstrated a high safety profile, with minor complications in 11.6% (n=72) and no major complications or procedure-related mortality. </p><p>Advanced age was significantly associated with higher diagnostic yield on endobronchial biopsy (p<0.001), bronchoalveolar lavage (p=0.018), and abnormal CT findings (p=0.03), but not with procedural complications (p=0.956). </p><p><br></p>
<p>Fibreoptic bronchoscopy is a safe, high-yield diagnostic tool for lung malignancy and tuberculosis; prioritising elderly patients with radiological abnormalities may enable earlier diagnosis.</p>
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Fibreoptic bronchoscopy; Diagnostic yield; Safety
maximum 3 keywords and no abbreviations, separated by commas
none
334